BioLinker

BrazilHealthtech

BioLinker is a Brazilian startup that synthesizes DNA and utilizes artificial intelligence to advance biotechnological capabilities, with a specific operational focus in the Amazon region. The company operates an automated laboratory and leverages capital from the Axcell fund, supported by investors from the Manaus Free Trade Zone, to drive its technical infrastructure and team expansion. While specific customer segments are not detailed in the provided evidence, the company is actively scaling its operations within Brazil, aiming to enhance its workforce to 24 employees. The integration of AI with DNA synthesis suggests a focus on data-driven biotech solutions, positioning the company within the intersection of health and technology sectors.

Website